Tranexamic Acid Study

Withdrawn before enrolling · Not applicable

Conditions studied: Arthroplasty, Replacement, Hip

In brief

The purpose of this study is to determine if tranexamic acid significantly reduces blood loss and blood transfusion in revision total hip replacement. Tranexamic acid is a drug that helps to reduce blood loss during surgery. Revision total hip replacement surgery is treatment for patients who have previously had hipe replacement surgery which failed and must be repaired/replaced.

Key facts

Study ID

NCT00375440

Run by

Texas Tech University Health Sciences Center

People needed

0

Starts

2005-02-01

Expected to finish

2008-01-01

Last updated by the study team

2015-10-05

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Failed primary total hip arthroplasty (femoral stem, acetabular component, or both)
• 18-100 years of age

You may not qualify if…

• Prosthetic infection
• Primary total hip arthroplasty
• Prisoners
• Pregnancy
• Previous adverse reaction to tranexamic acid
• Bleeding/coagulation disorders
• Renal insufficiency (serum creatinine>two standard deviations for age)
• History of deep venous thrombosis or pulmonary embolism
• Religious beliefs/practices prohibiting blood transfusions
• Wards of the state
• Cognitively impaired patients
• Terminally ill patients
• Students and/or employees
• Color blindness

Where it is running

• Texas Tech University Health Sciences Center Department of Orthopaedic Surgery — Lubbock, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.